Log in to search using one of your social media accounts:

 

Building better tiny kidneys to test drugs and help people avoid dialysis
(University of Southern California) A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies. The three-study series provides the first cellular and molecular characterization of how the human kidney develops in a mother's womb. The new, open-source data, available at www.gudmap.org, provides the first systematic, high-resolution atlas or databank for human kidney genesis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 15, 2018 Category: International Medicine & Public Health Source Type: news

Wearable Artificial Kidney Could be Game Changer
Most innovations medicine occur by asking one simple question. Is there a better way? Physicians at the Kidney Research Institute of the University of Washington have asked that question about hemodialysis treatments – lengthy procedures that filter a patient’s blood when the kidneys no longer function properly. The institute is developing a wearable artificial kidney that could completely change the paradigm for some of these patients with impaired kidney function. Earlier this week, at MD&M West, Jonathan Himmelfarb, MD, who servers as director of the Kidney Research Institute, spoke about the develo...
Source: MDDI - February 8, 2018 Category: Medical Devices Authors: Omar Ford Tags: Medical Device Business Source Type: news

WHO calls for sustainable solution to health sector power shortages in Gaza
8 February, 2018, Gaza Strip – Gaza’s health sector was on the verge of collapse due to dwindling fuel supplies until the United Arab Emirates stepped in this week with a US$2 million grant to sustain hospital backup generators for critical health services. The donation will provide enough fuel to keep facilities running for several months.  “The UAE’s timely support will save lives, but a more sustainable solution is required to address the chronic fuel and power shortages in Gaza that leave health facilities consistently on the verge of closure,” says Dr. Gerald Rockenschaub, Head of W...
Source: WHO EMRO News - February 8, 2018 Category: Middle East Health Source Type: news

From the heart: The tale of a three-time transplant recipient
Playing youth hockey and Little League in the spring of 1988, I started to become easily fatigued. I became very weak and could no longer run around. By May, a visit to my pediatrician resulted in a trip to the Boston Children’s Hospital Cardiology Clinic on Fegan 6 and the first of many cardiac catheterizations I would receive in my life. The results of that first procedure were shared in my corner room across from the nurses’ station on 6 East (the cardiac step-down at the time): I would need a heart transplant for cardiomyopathy. It was Friday the 13th. I was 10 years old. Tim, before he ...
Source: Thrive, Children's Hospital Boston - February 7, 2018 Category: Pediatrics Authors: Tim Gallagher Tags: Our Patients’ Stories cardiac catheterization cardiomyopathy heart transplant Heart transplant program kidney transplant Pediatric Transplant Center (PTC) Source Type: news

TVA Medical touts meta-analysis of everlinQ endoAVF treatments
TVA Medical today released data from a meta-analysis study of its everlinQ endovascular arteriovenous fistula system designed for hemodialysis access, touting a high procedure success rate and a high rate of fistula maturation. Results from the 236-patient trial were presented at the Leipzig Interventional Course 2018, the Austin, Texas-based company said. Data in the meta-analysis came from four clinical studies and 79 commercial cases, and indicated a 96.8% and 97.8% procedure success rate in clinical studies and real-world cases, respectively, as well as an acceptable safety profile. The results also indicated 88% fistu...
Source: Mass Device - February 2, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Vascular TVA Medical Source Type: news

Fresenius Medical pays $4m to settle HIPAA violations
Fresenius Medical Care (NYSE:FMS; ETR:FRE) has agreed to pay $3.5 million to the US Department of Health and Human Services Office for Civil Rights to settle five breaches of the Health Insurance Portability and Accountability Act Privacy and Security Rules. Fresenius reportedly submitted five separate breach reports on Jan. 23, 2013 for separate incidents between Feb. 23, 2012 and July 18, 2012 that implicated electronic protected health information of five of Fresenius’ covered entities. The locations of the breaches were the Jacksonville, Fla.-based Fresenius Medical Care Duval Facility, the Semmes, Ala.-based Fre...
Source: Mass Device - February 2, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Regulatory/Compliance Fresenius Source Type: news

Nigeria:Lassa Fever - Obaseki Releases N100m for Medical Equipment
[This Day] Benin City -To further curtail the spread and outbreak of Lassa Fever owing to the rising number of patients being referred to Irrua Specialists Teaching Hospital for treatment, Edo State Governor, Mr. Godwin Obaseki, has ordered the immediate release of N100 million as first tranche payment for the procurement of four dialysis machines, ventilators, Personal Protective Equipment, drugs and other consumables required for the treatment of Lassa Fever patients. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 2, 2018 Category: African Health Source Type: news

Nigeria:Obaseki Releases N100 Million for Lassa Fever, Dialysis Equipment
[Premium Times] The Governor of Edo State, Godwin Obaseki, has ordered the immediate release of N100 million as first tranche payment for the procurement of four dialysis machines, ventilators, Personal Protective Equipment, drugs and other consumables required for the treatment of Lassa Fever patients. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 2, 2018 Category: African Health Source Type: news

Could a Wearable Help Prevent Pressure Injuries?
This study is an important step towards redefining the standard of care for pressure injury prevention." To learn more, visit www.leafhealthcare.com. [ALL IMAGES COURTESY OF LEAF HEALTHCARE] At the upcoming Medical Design & Manufacturing West 2018 conference, don't miss this compelling session: "Design for Demand" The Wearable Artifical Kidney Story," by Jonathan Himmelfarb, MD (Director, Kidney Research Institute), on Tuesday, February 6, at 9:30am - 10:00am. Dr.  Himmelfarb will explain the "creation of a wearable alternative to conventional dialysis treatment and the...
Source: MDDI - January 30, 2018 Category: Medical Devices Authors: Daphne Allen Tags: Digital Health Source Type: news

Comprehensive up-to-date review of toxic alcohol poisoning
3.5 out of 5 stars Toxic Alcohols. Kraut JA, Mullins ME. N Engl J Med 2018 Jan 18;378:270-280. Reference This is a good general review and update of clinical issues regarding the major toxic alcohols: methanol, ethylene glycol, isopropanol, diethylene glycol, and propylene glycol. The article is chockablock with information, and would I think be somewhat difficult to follow if one was not already familiar with these agents. For those wishing to learn the subject de novo, a good introductory book chapter in a toxicology or emergency medicine text would be better. But this is a very good refresher for those already...
Source: The Poison Review - January 30, 2018 Category: Toxicology Authors: Leon Gussow Tags: Medical diethylene glycol isopropanol methanol propylene glycol Review toxic alcohol Source Type: news

Dialysis abroad
When Javier Artigas saved the life of a famous writer it led to a meeting with a billionaire - which enabled him to help kidney dialysis patients travel the world. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - January 25, 2018 Category: Consumer Health News Source Type: news

Serious fall injury history and adverse health outcomes after initiating hemodialysis among older U.S. adults - Bowling CB, Hall R, Khakharia A, Franch HA, Plantinga LC.
BACKGROUND: Although older adults with pre-dialysis chronic kidney disease (CKD) are at higher risk for falls, the prognostic significance of a serious fall injury prior to dialysis initiation has not been well described in the end-stage renal disease popu... (Source: SafetyLit)
Source: SafetyLit - January 22, 2018 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Laminate Medical launches study of VasQ hemodialysis fistula device
Laminate Medical Technologies said today it launched a pivotal, FDA-cleared trial of its VasQ implanted blood vessel device designed for patients requiring arteriovenous fistulas as vascular access for hemodialysis. The Israel-based company’s VasQ device is designed to aid kidney failure patients in need of dialysis by providing external support to reduce fistula failure. The device regulates flow by constraining and shaping the fistula and reinforces and shields the perianastomotic vein against high pressure, wall tension and flow levels, the company said. The first procedures in the trial were recently perform...
Source: Mass Device - January 19, 2018 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Clinical Trials Vascular Laminate Medical Technologies Source Type: news

These medtech companies raised the most VC last year
[Image from unsplash.com]Perhaps there’s a ray of hope that venture capital funding is recovering a bit for the medical device industry. VC firms invested more than $2.8 billion in 2017, an increase of more than $647 million from 2016, according to the MoneyTree Report from PricewaterhouseCoopers (PwC) and CB Insights. There were a total 229 deals involving medical device companies last year. The companies raking in the VC cash are doing everything from creating robotic microsurgery for the eyes to building better dialysis machines to bringing neuromodulation to bear on epilepsy. Read on to discover which medtech com...
Source: Mass Device - January 19, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: Cardiovascular Funding Roundup Hospital Care Implants mHealth (Mobile Health) Advanced Cardiac Therapeutics Inc. Auris Surgical Robotics Cereve EarLens Ebb Therapeutics EBR Systems Inc. Fractyl Laboratories immusant MedTech Mox Source Type: news

Surgery to remove blood clot saves London ’s kidneys
Todd and Lindsey Taylor had barely settled in at home in Syracuse, New York with their new baby, London, when their world turned upside down. London, who had seemed perfectly healthy at birth, woke up nine days later vomiting and struggling to breathe. They rushed her to their local children’s hospital. “The doctors did an ultrasound and found a large blood clot in her aorta that was blocking the flow of blood to her kidneys,” says Todd. “They said she was in near fatal condition when we arrived, but they put her on dialysis and were able to stabilize her.” Desperate for options The doctors in...
Source: Thrive, Children's Hospital Boston - January 19, 2018 Category: Pediatrics Authors: Ellen Greenlaw Tags: Diseases & Conditions Our Patients’ Stories blood clot Dr. Anne Hansen Dr. Heung-Bae Kim Midaortic Syndrome and Renovascular Hypertension (MAS/RVH) Program neonatal intensive care unit Source Type: news

10 Global Health Issues to Watch in 2018
January 19, 2018It ’s notallbad news.When we set out to compile our annual list of global health issues to watch this year, it seemed like all bad news. And true, that ’s often what we deal with in global health—the problems that need tackling, the suffering we can help alleviate.But then stories and columns likethis one cheer us up. They remind us that no matter how complicated and frustrating our work may get, fighting back against poverty and inequality works.There are and always will be global health challenges to face. But there ’s boundless hope, too. And a field full of determined health work...
Source: IntraHealth International - January 19, 2018 Category: International Medicine & Public Health Authors: mnathe Source Type: news

Baxter subsidiary sues B. Braun over blood filtration system
Baxter (NYSE:BAX) and its subsidiary Gambro filed a patent infringement lawsuit against B. Braun last week, claiming that the German medical device maker’s Omni blood purification system infringes on seven of the patents covering Baxter’s Prismaflex system. The devices are used to treat patients who have acute kidney injuries and need help filtering out the waste products that accumulate in the blood. Both the Omni system and the Prismaflex system deliver continuous renal replacement therapy – a form of hemodialysis where the patient’s blood is removed and processed through a hemofilter. B...
Source: Mass Device - January 18, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Legal News Wall Street Beat B. Braun Baxter Gambro Source Type: news

Bluegrass Vascular launches pivotal study for Surfacer vascular access catheter
Bluegrass Vascular Technologies said it enrolled the first patients in a pivotal trial of its Surfacer “inside-out” vascular access catheter. The Surfacer device is designed to provide access to the jugular vein to restore central venous access in hemodialysis patients with blocked neck veins; it won CE Mark approval in the European Union in August 2016; Bluegrass later inked an EU distribution deal with Merit Medical (NSDQ:MMSI) that included an equity stake. Surfacer is designed to be threaded through the femoral vein up to and into blockages in the jugular, which acts as a stabi...
Source: Mass Device - January 18, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Clinical Trials Vascular Bluegrass Vascular Technologies Source Type: news

Smiths updates recall for Medfusion syringe pumps
Smiths Medical has amended an urgent medical device recall that it first issued in August for its Medfusion syringe pump model series 3500 and 4000. After acknowledging that a defect in certain models of the pump can cause an “invalid syringe size” alarm to go off, the company added an option for facilities with trained staff to perform the repair onsite. Get the full story at our sister site, Drug Delivery Business News. The post Smiths updates recall for Medfusion syringe pumps appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - January 18, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Dialysis Drug Pumps Drug-Device Combinations Hospital Care Pharmaceuticals Recalls Smiths Medical Source Type: news

Diagnosis of CKDs Using Urinary Proteome Analysis Diagnosis of CKDs Using Urinary Proteome Analysis
Could urinary proteome analyses provide a non-invasive alternative to kidney biopsy for the diagnosis of chronic kidney diseases?Nephrology Dialysis Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 16, 2018 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

Autogenous Conduits for Leg Bypass Surgery Used Less Often in Female Dialysis Patients Autogenous Conduits for Leg Bypass Surgery Used Less Often in Female Dialysis Patients
Autogenous conduits improve patency in hemodialysis patients undergoing lower-extremity bypass surgery, but are used less often in women than in men, new research shows.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - January 8, 2018 Category: Surgery Tags: General Surgery News Source Type: news

Can Angiodynamics Level the PICC Playing Field?
Angiodynamics is still trying to level the competitive playing field for its peripherally inserted central catheters (PICCs). "We continue to believe that if our PICCs are able to compete on  a level playing field, we can gain share in this market, particularly given the gains we have seen from our BioFlow Midline ports and dialysis product families," said Jim Clemmer, the company's president and CEO, during Angiodynamics' most recent earnings call. According to SeekingAlpha transcripts of the call, its lawsuit against C.R. Bard is "moving forward as planned." Hear industry luminaries share th...
Source: MDDI - January 5, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Cardiovascular Medical Device Business Source Type: news

These lab-grown blood vessel replacements could benefit dialysis patients
[Image from University of Minnesota]University of Minnesota researchers have developed a blood vessel replacement made of biological materials in a lab. The lab-grown vessels have no living cells at implantation and could be used as a graft for kidney dialysis patients. The lab-engineered blood vessel replacement is the first nonsynthetic, decellularized graft that is repopulated with cells using the recipient’s cells when implanted. The grafts could also be used as coronary and peripheral bypass blood vessel and tubular heart valves. Approximately 480,000 people are on dialysis in the U.S., according to the National...
Source: Mass Device - January 3, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: Implants Regenerative Medicine Research & Development kidney dialysis MedTech University of Minnesota Source Type: news

Investigation and Management of Renal Stone Disease Investigation and Management of Renal Stone Disease
Gain a better understanding of the optimal diagnostic and management strategies for nephrolithiasis.Nephrology Dialysis Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 2, 2018 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

BD Clears Final Regulatory Hurdle for Bard Deal
Becton, Dickinson and Company (BD) said Thursday that its pending acquisition of C.R. Bard has been cleared by the Ministry of Commerce of the People's Republic of China (MOFCOM). Franklin Lakes, NJ-based BD now plans to close the deal Friday, so long as the MOFCOM also approves Merit Medical as the buyer for its soft tissue core needle biopsy product line divestiture. MOFCOM cleared the Bard acquisition on the condition that BD divests its soft tissue core needle biopsy product line. This was the final regulatory approval needed to complete the Bard deal, said Vincent Forlenza, chairman and CEO of BD.  BD broke ...
Source: MDDI - December 28, 2017 Category: Medical Devices Authors: Amanda Pedersen Tags: Medical Device Business Cardiovascular Source Type: news

AKI Ascertainment for Clinical and Preclinical Studies AKI Ascertainment for Clinical and Preclinical Studies
How do clinical and preclinical interventional studies differ in their use of acute kidney injury biomarkers?Nephrology Dialysis Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 26, 2017 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

Microbiome Perturbation Reduces Plasma Concentration in ESRD Microbiome Perturbation Reduces Plasma Concentration in ESRD
A study examines the effects of vancomycin on plasma concentrations of two gut-derived uremic solutes in ESRD. What are the implications?Nephrology Dialysis Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 21, 2017 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

Emergency dialysis for undocumented immigrants tied to more deaths
(Reuters Health) - - Undocumented immigrants with kidney failure who can only get emergency dialysis have worse survival odds than patients who get routine dialysis three times a week, a U.S. study suggests.   (Source: Reuters: Health)
Source: Reuters: Health - December 20, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Patients on Dialysis: Advice on BP and Fluid Intake Patients on Dialysis: Advice on BP and Fluid Intake
How much fluid should a patient on dialysis consume? What blood pressure range is optimal for these patients? Dr Szczech offers her advice on what to tell patients on dialysis.Medscape Nephrology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 20, 2017 Category: Consumer Health News Tags: Nephrology Commentary Source Type: news

Emergency-Only Dialysis Ups Deaths in Undocumented Immigrants Emergency-Only Dialysis Ups Deaths in Undocumented Immigrants
Undocumented immigrants with end-stage renal disease who accessed hemodialysis on a emergency-only basis were more likely to die and to spend more time hospitalized, a study found.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 19, 2017 Category: Consumer Health News Tags: Nephrology News Source Type: news

Uric Acid, Protein and Mortality in Hemodialysis Patients Uric Acid, Protein and Mortality in Hemodialysis Patients
What do we currently know about the association between uric acid concentrations and mortality in hemodialysis patients -- and how does protein intake fit into the equation?Nephrology Dialysis Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 19, 2017 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

State Rules Affect Survival of Immigrants with Kidney Failure
Source: HealthDay Related MedlinePlus Pages: Dialysis, Kidney Failure (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - December 18, 2017 Category: Consumer Health News Source Type: news

Sudan:Deadly Drink Kills At Least Ten, Blinds Two in East Darfur
[Radio Dabanga] ED Daein -At least ten patients have died after drinking locally produced wine, while several people are being treated in a dialysis center in Khor Omar neighbourhood in Ed Daein, East Darfur. Others became blind. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 18, 2017 Category: African Health Source Type: news

Singapore vascular access dev Advent Access raises $2m in pre-Series A
Singapore-based vascular access dev Advent Access has raised $1.9 million (SGD $2.6 million) in a pre-Series A financing round to support its av-Guardian technology designed to create vascular access for dialysis patients. The funding round was led by Accuron MedTech, which the company touted as the largest medical device company in southeast Asia. The investment went through Singapore’s Spring Seeds Capital-assigned accelerator the Med Tech Alliance, Advent Access said. “We are excited to lead the pre-Series A investment in Advent Access given the company’s strong progress and potential to transform and ...
Source: Mass Device - December 14, 2017 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Business/Financial News Vascular adventaccess Source Type: news

Manifestations of Lupus in the Kidney and How to Manage Them Manifestations of Lupus in the Kidney and How to Manage Them
Find out what there is to know regarding the diagnosis of lupus nephritis and the available and emerging treatment strategies.Nephrology Dialysis Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 14, 2017 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

Body Weight Changes and Mortality in Hemodialysis Patients Body Weight Changes and Mortality in Hemodialysis Patients
A new study examines the association of post-dialysis weight changes with all-cause mortality in hemodialysis patients.Nephrology Dialysis Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 12, 2017 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

Dialysis
Title: DialysisCategory: Procedures and TestsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 12/11/2017 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - December 11, 2017 Category: Nutrition Source Type: news

NxStage touts reduced technique failure in Nx2me home hemodialysis study
NxStage Medical (NSDQ:NXTM) today released the results from a study of its Nx2me connected health remote patient management system for patients using home hemodialysis, touting a 29% reduction in technique failure of conversion to in-center hemodialysis by 29%. Results from the study were published in the journal Hemodialysis International, the Lawrence, Mass.-based company said. Data came from a total 606 Nx2me users including both patients on home hemodialysis with the NxStage System One and new home hemodialysis patients, NxStage said. Technique failure was reduced by 34% For patients who began to use the Nx2m...
Source: Mass Device - December 8, 2017 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Clinical Trials Patient Monitoring NxStage Medical Inc. Source Type: news

Safety of IV Ferric Carboxymaltose vs Oral Iron in CKD Safety of IV Ferric Carboxymaltose vs Oral Iron in CKD
What does the evidence tell us about the safety of IV iron therapy in patients with CKD?Nephrology Dialysis Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 7, 2017 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

Perceptions of Dialysis Initiation and Modality Decisions Perceptions of Dialysis Initiation and Modality Decisions
How involved do patients feel about the decision to start dialysis -- and how might their perception impact treatment satisfaction?Nephrology Dialysis Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 5, 2017 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

Vascular Access Creation and Slowing of eGFR Decline in CKD Vascular Access Creation and Slowing of eGFR Decline in CKD
A study examines whether vascular access creation is associated with slowing of eGFR decline in patients with advanced CKD transitioning to dialysis.Nephrology Dialysis Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 1, 2017 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

Kidney disease drug recommended by Nice 'may do more harm than good'
Exclusive: Little evidence that phosphate binders improve patient wellbeing, warn experts, while one type may contribute to increased risk of cardiovascular diseaseThe UK ’s drug guidelines body is recommending a type of medication to treat chronic kidney disease despite no firm evidence that it benefits patients – and some signs that the drugs may do more harm than good, experts have warned.Phosphate binders are commonly prescribed to lower blood phosphate levels in patients with advanced kidney disease, including those on dialysis. High phosphate has been linked to worse patient outcomes, including bone and m...
Source: Guardian Unlimited Science - November 24, 2017 Category: Science Authors: Nicola Davis Tags: Drugs The National Institute for Health and Care Excellence (Nice) NHS Society Science Source Type: news

Company seeks approval for $2.08 million dialysis facility in Triad
Total Renal Care of North Carolina has applied for state approval to develop a 10-station dialysis facility in Guilford County.   The more than $2.08 million project would move seven stations from Reidsville Dialysis and three stations from Burlington Dialysis to a new facility, according to the certificate-of-need application. Total Renal Care, doing business as Guilford County Dialysis, is a subsidiary of DaVita Inc., based in Colorado. Wake Forest Health University Health Sciences, which owns… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - November 22, 2017 Category: Health Management Authors: Jessica Seaman Source Type: news

Company seeks approval for $2.08 million dialysis facility in Triad
Total Renal Care of North Carolina has applied for state approval to develop a 10-station dialysis facility in Guilford County.   The more than $2.08 million project would move seven stations from Reidsville Dialysis and three stations from Burlington Dialysis to a new facility, according to the certificate-of-need application. Total Renal Care, doing business as Guilford County Dialysis, is a subsidiary of DaVita Inc., based in Colorado. Wake Forest Health University Health Sciences, which owns… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 22, 2017 Category: Biotechnology Authors: Jessica Seaman Source Type: news

Fresenius gets in on $3m Modulated Imaging Series A
Medtech imaging developer Modulated Imaging said today it closed a $2.9 million Series A financing round that was joined by dialysis giant Fresenius Medical Care‘s (NYSE:FMS; ETR:FRE) Ventures arm. The round was led by Grey Sky Venture Partners and joined by Mitsubishi UFJ Capital, Fresenius Medical Care Ventures and Hamamatsu Photonics’ Photonics Management Corporation, the Irvine, Calif.-based company said. “Hamamatsu Photonics has invested in Modulated Imaging once again due to its innovative work with photonics to improve human health. Modulated Imaging’s technology is very much in sync with Ham...
Source: Mass Device - November 20, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Imaging Fresenius modulatedimaging Source Type: news

Another dialysis clinic approved for Erie County
A Texas-based dialysis company will build its third clinic in the region, following a contingent approval this week from the state Department of Health. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - November 16, 2017 Category: Health Management Authors: Tracey Drury Source Type: news

Nigeria:Lions Club Proposes N200 Million Dialysis Centre
[Guardian] As part of measures to improve healthcare delivery and immortalise Dr. Isaac Olusola Dada, the Lions Club Nigeria has proposed a N200 million state-of-the-art dialysis centre in Lagos. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 16, 2017 Category: African Health Source Type: news

Expanding geographic sharing of donor kidneys would increase transplants, study finds
(University of Kansas) Based on their analysis, the researchers suggest that changing how so-called lower quality kidneys are allocated geographically could result in anywhere from 58 additional to 174 additional kidney transplants per year to help more patients get off dialysis treatments and live more normal lives. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 14, 2017 Category: International Medicine & Public Health Source Type: news

Saving lives with a new liver dialysis device
New technology could soon revolutionise the treatment of liver failure: an innovative dialysis device is currently being trialled. It aims to greatly improve the outlook for patients, helping them to recover or supporting them while they wait for a transplant, say the EU-funded researchers taking this innovation forward. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - November 14, 2017 Category: Research Source Type: news

Nanotechnology Poised to Transform Fistula Creation Nanotechnology Poised to Transform Fistula Creation
A new approach could allow interventionalists to create an arteriovenous fistula for hemodialysis access in an office-based procedure, report investigators.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 9, 2017 Category: Consumer Health News Tags: Nephrology News Source Type: news